Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -1.35 is 87% below its 5-year average of -0.72, around the middle of its 5-year range (-6.00–1.15).
As of the fiscal period ended Tuesday, June 30, 2026. 4.19% below its 12-month average of -1.29.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -1.35.
DEBT TO EQUITY RATIO
-1.35
DEBT TO EQUITY RATIO AVG TTM
-1.29
DEBT TO EQUITY RATIO AVG 3Y
-1.37
DEBT TO EQUITY RATIO AVG 5Y
-0.72
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.19%
CURRENT VS 3Y AVG
+1.72%
CURRENT VS 5Y AVG
-87.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 773 covered companies
CURRENT VS SECTOR MEDIAN
-1326.00%
vs the sector median at left
Spectral AI, Inc.
Market Cap
$52.83M
Debt to Equity Ratio
-1.35
TTM Avg
-1.29
3Y Avg
-1.37
5Y Avg
-0.72
Market Cap
$52.60M
Debt to Equity Ratio
0.30
TTM Avg
0.30
3Y Avg
0.29
5Y Avg
0.25
Market Cap
$51.99M
Debt to Equity Ratio
0.00
TTM Avg
0.89
3Y Avg
0.55
5Y Avg
0.44
Market Cap
$53.70M
Debt to Equity Ratio
0.05
TTM Avg
0.11
3Y Avg
0.11
5Y Avg
0.11
Market Cap
$54.14M
Debt to Equity Ratio
0.09
TTM Avg
7.52
3Y Avg
4.55
5Y Avg
3.64
Market Cap
$51.19M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.15
5Y Avg
0.12
Market Cap
$51.12M
Debt to Equity Ratio
0.00
TTM Avg
0.12
3Y Avg
0.06
5Y Avg
0.04
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spectral AI, Inc. (MDAI) | $52.83M | -1.35 | -1.29 | -1.37 | -0.72 |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | 0.30 | 0.30 | 0.29 | 0.25 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | 0.00 | 0.89 | 0.55 | 0.44 |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | 0.05 | 0.11 | 0.11 | 0.11 |
| ImageneBio Inc (IMA)vs › | $51.88M | 0.01 | 0.07 | 0.06 | 0.05 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | 0.09 | 7.52 | 4.55 | 3.64 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.30 | 0.25 | 0.31 | 0.39 |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | 0.00 | 0.00 | 0.15 | 0.12 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00 | 0.12 | 0.06 | 0.04 |
| Aldeyra The (ALDX)vs › | $55.25M | 0.00 | 0.28 | 0.20 | 0.19 |
Debt/Equity
-1.35
Current Ratio
0.90
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -1.35 |
| 2026-03-31 | -1.13 |
| 2025-12-31 | -1.76 |
| 2025-09-30 | -1.18 |
| 2025-06-30 | -1.05 |
| 2025-03-31 | -6.00 |
| 2024-12-31 | -0.65 |
| 2024-09-30 | -1.86 |
| 2024-06-30 | -2.41 |
| 2024-03-31 | -3.16 |
| 2023-12-31 | -0.75 |
| 2023-09-30 | 1.15 |
| 2023-06-30 | 0.20 |
| 2023-03-31 | 0.12 |
| 2022-12-31 | 0.10 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 0.04 |
| 2021-09-30 | 0.00 |
